BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 77.44% institutional investors, 0.78% insiders, and 21.79% retail investors. Blackrock is the largest institutional shareholder, holding 12.04% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.09% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical77.44%0.78%21.79%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.74M12.04%$1.87B
Blackrock funding, inc. /de22.05M11.52%$1.19B
Vanguard group18.58M9.71%$1.01B
Primecap management co/ca/15.23M7.96%$824.82M
Dodge & cox14.69M7.67%$795.44M
State street8.76M4.58%$474.69M
Viking global investors lp8.32M4.35%$450.73M
Norges bank3.57M1.87%$234.64M
Geode capital management3.54M1.85%$191.29M
Capital research global investors2.54M1.33%$137.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management405.45K9.36%$21.96M
Palo alto investors lp754.01K7.56%$40.84M
Boone capital management328.55K5.83%$17.79M
Eagle health investments lp366.81K5.22%$19.87M
Camber capital management lp600.00K3.10%$32.98M
Sio capital management225.11K3.09%$12.19M
Diadema partners lp212.88K2.95%$11.53M
Soleus capital management890.30K2.43%$48.22M
Sector gamma as175.85K2.36%$9.52M
Novo660.00K2.30%$35.75M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank3.57M0.03%3.57M
Capital research global investors2.54M0.03%2.15M
Los angeles capital management1.33M0.24%1.05M
Brandywine global investment management906.03K0.34%906.03K

Top Sellers

HolderShares% AssetsChange
Viking global investors lp8.32M1.17%-3.97M
Elliott investment management---3.50M
Blackrock funding, inc. /de22.05M0.02%-1.96M
Avoro capital advisors---1.46M
Morgan stanley1.38M0.00%-1.05M

New Positions

HolderShares% AssetsChangeValue
Norges bank3.57M0.03%3.57M$234.64M
Brandywine global investment management906.03K0.34%906.03K$49.07M
Braidwell lp528.00K0.85%528.00K$28.60M
Krensavage asset management405.45K9.36%405.45K$21.96M
Axa investment managers362.95K0.05%362.95K$19.66M

Sold Out

HolderChange
Blume capital management-2.00
Householder group estate & retirement specialist-3.00
Raleigh capital management-4.00
Bokf, na-4.00
Financial gravity asset management-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025521-13.60%148,245,021-13.91%770.96%255-20.56%182-1.62%
Jun 30, 2025611-0.97%183,457,4080.41%951.05%322-5.57%1886.82%
Mar 31, 202511-98.11%305,544-99.83%-0.00%7-97.61%1-99.45%
Dec 31, 2024565-5.04%182,776,8923.30%951.11%2852.15%178-10.55%
Sep 30, 2024591-0.17%176,679,197-4.12%920.97%279-3.13%1957.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.09%-
Capital Group Growth Fnd of Amer Comp8.28M4.32%741.56K
American Funds Growth Fund of Amer A8.28M4.32%741.56K
iShares Core S&P Mid-Cap ETF6.24M3.25%-
Vanguard US Total Market Shares ETF6.04M3.15%4.43K
Vanguard Total Stock Mkt Idx Inv6.02M3.14%-127.23K
Vanguard PRIMECAP Inv5.76M3.00%-1.33M
Vanguard Capital Opportunity Inv5.28M2.75%-223.03K
Vanguard Small Cap Index4.66M2.43%-29.83K
Capital Group AMCAP Composite4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
May 20, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$105.93K
May 02, 2025Hubbard Cristin EVP, Chief Commercial OfficerSell$17.72K
Mar 19, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$92.62K
Mar 06, 2025Guyer Charles Greg EVP, Chief Technical OfficerSell$501.36K
Feb 24, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$91.90K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2-2
2025 Q1-3
2024 Q4-1
2024 Q3-1

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 77.44%, followed by 0.78% insiders and 21.78% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 45.24%, which BioMarin Pharmaceutical exceeds.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock (22.74M shares, 12.04%), Blackrock funding, inc. /de (22.05M shares, 11.52%), and Vanguard group (18.58M shares, 9.71%). Together, they hold 33.26% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 9.36% of its assets in 405.45K BioMarin Pharmaceutical shares, valued at 21.96M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.09% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools